Home / Health / Insulin Pod Defect: Diabetes Tech Recalled
Insulin Pod Defect: Diabetes Tech Recalled
13 Mar
Summary
- Manufacturing defect in insulin pods can cause leaks.
- High blood sugar and serious health issues may occur.
- 18 reports of serious adverse events, including hospitalizations, received.
Insulet is recalling certain batches of its Omnipod 5 automated insulin delivery system in the United States. The recall was initiated after a manufacturing defect was identified, specifically a small tear in internal tubing that can lead to insulin leakage within the device. This malfunction prevents diabetic users from receiving their full prescribed dose of insulin.
The consequence of this defect is a potential for elevated blood sugar levels. In severe instances, this can escalate to diabetic ketoacidosis, a serious condition requiring urgent medical intervention. Insulet has reported receiving 18 adverse event reports related to this issue, including hospitalizations.
The company has assured that only specific lots are affected and all other Omnipod 5 devices remain safe for use. The U.S. Food and Drug Administration has been notified of the situation. Shares of Insulet experienced a nearly 7% decline in extended trading following the announcement.
